StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis total assets

Total assets on the balance sheet at the end of each period.

Enovis's total assets was $3.77B at Jul 3, 2026. For fiscal 2025 it was $3.83B, down 18.7% from the year before. Over ten years it grew -5.5% a year on average. The highest annual figure on record is $8.52B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.83B-18.7%
FY2024Dec 31, 2024$4.72B+4.6%
FY2023Dec 31, 2023$4.51B+5.5%
FY2022Dec 31, 2022$4.27B-49.8%
FY2021Dec 31, 2021$8.52B+15.8%
FY2020Dec 31, 2020$7.35B-0.5%
FY2019Dec 31, 2019$7.39B+11.7%
FY2018Dec 31, 2018$6.62B-1.4%
FY2017Dec 31, 2017$6.71B+5.9%
FY2016Dec 31, 2016$6.34B-5.9%
FY2015Dec 31, 2015$6.73B-6.6%
FY2014Dec 31, 2014$7.21B+9.2%
FY2013Dec 31, 2013$6.60B+7.4%
FY2012Dec 31, 2012$6.15B+464.8%
FY2011Dec 31, 2011$1.09B+6.5%
FY2010Dec 31, 2010$1.02B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$3.77B-25.0%
Q1 FY2026Apr 3, 2026$3.83B-21.4%
Q4 FY2025Dec 31, 2025$3.83B-18.7%
Q3 FY2025Oct 3, 2025$4.43B-20.1%
Q2 FY2025Jul 4, 2025$5.02B-7.7%
Q1 FY2025Apr 4, 2025$4.88B-11.0%
Q4 FY2024Dec 31, 2024$4.72B+4.6%
Q3 FY2024Sep 27, 2024$5.55B+26.1%
Q2 FY2024Jun 28, 2024$5.44B+22.5%
Q1 FY2024Mar 29, 2024$5.48B+27.4%
Q4 FY2023Dec 31, 2023$4.51B+5.5%
Q3 FY2023Sep 29, 2023$4.40B-1.0%
Q2 FY2023Jun 30, 2023$4.44B-1.3%
Q1 FY2023Mar 31, 2023$4.30B-49.3%
Q4 FY2022Dec 31, 2022$4.27B-49.8%
Q3 FY2022Sep 30, 2022$4.44B-44.2%
Q2 FY2022Jul 1, 2022$4.50B-40.4%
Q1 FY2022Apr 1, 2022$8.48B+5.2%
Q4 FY2021Dec 31, 2021$8.52B+15.8%
Q3 FY2021Oct 1, 2021$7.97B+11.4%
Q2 FY2021Jul 2, 2021$7.56B+6.1%
Q1 FY2021Apr 2, 2021$8.07B+8.2%
Q4 FY2020Dec 31, 2020$7.35B-0.5%
Q3 FY2020Oct 2, 2020$7.15B-25.4%
Q2 FY2020Jul 3, 2020$7.12B-28.0%
Q1 FY2020Apr 3, 2020$7.46B-29.0%
Q4 FY2019Dec 31, 2019$7.39B+11.7%
Q3 FY2019Sep 27, 2019$9.59B+48.8%
Q2 FY2019Jun 28, 2019$9.90B+53.2%
Q1 FY2019Mar 29, 2019$10.50B+52.7%
Q4 FY2018Dec 31, 2018$6.62B-1.4%
Q3 FY2018Sep 28, 2018$6.45B-5.7%
Q2 FY2018Jun 29, 2018$6.46B-4.0%
Q1 FY2018Mar 31, 2018$6.88B+7.0%
Q4 FY2017Dec 31, 2017$6.71B+5.9%
Q3 FY2017Sep 29, 2017$6.84B+4.5%
Q2 FY2017Jun 30, 2017$6.73B–
Q1 FY2017Mar 31, 2017$6.43B–
Q4 FY2016Dec 31, 2016$6.34B–
Q3 FY2016Sep 30, 2016$6.54B–

More Enovis figures

See a number that looks wrong?